Thin choroid connected to serous retinal detachment development

Article

A thin choroid at the upper border of the inferior staphyloma is linked to serous retinal detachment development.

A thin choroid at the upper border of the inferior staphyloma is linked to serous retinal detachment development, reveals a paper in the journal Retina.

The study, led by Dr Tetsuya Yamagishi, Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan, included five eyes of five patients with inferior staphyloma and posterior serous retinal detachment.

Enhanced depth imaging using spectral domain optical coherence tomography was performed in the vertical section through the fovea. Fluorescein angiography and indocyanine green angiography were also conducted on each patient.

The choroid was the thinnest at the upper border of the staphyloma in all five eyes. Fluorescein angiography presented a band of window defects along the upper border of the staphyloma and indocyanine green angiography showed persistent hypoperfusion in all five eyes.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.